Inist to jointly develop oral ‘bazedoxifene/cholecalciferol’ combination drug
Inist Bio Pharmaceutical(CEO Kook-Hyun Kim) will conduct an open innovation service of its product based on its know-hows as a CMO(contract manufacturing organization).
The company will open a briefing to suggest joint development of a bazedoxifene/cholecalciferol combination drug being develope...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.